Showing results (61-70 of 71) with videos related to

Sort By:
Pageof 8
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|August 8, 2018
Brain Perfusion, Regional Volumes, and Cognitive Function in Human Immunodeficiency Virus-positive Patients Treated With Protease Inhibitor MonotherapyLewis J Haddow, Claudia Godi, Magdalena Sokolska, et al.
Scientific Reports|October 9, 2021
SARS-CoV-2 inhibition using a mucoadhesive, amphiphilic chitosan that may serve as an anti-viral nasal sprayKrzysztof Pyrć, Aleksandra Milewska, Emilia Barreto Duran, et al.
BMJ Open|December 10, 2023
How surgical Trainee Research Collaboratives achieve success: a mixed methods study to develop trainee engagement strategiesClare Clement, Karen Coulman, Nick Heywood, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|March 15, 2018
Risk of Suicidal Behavior With Use of Efavirenz: Results from the Strategic Timing of Antiretroviral Treatment TrialAlejandro Arenas-Pinto, Birgit Grund, Shweta Sharma, et al.
The Journal of Infectious Diseases|May 11, 2021
Human Immunotypes Impose Selection on Viral Genotypes Through Viral Epitope SpecificityMigle Gabrielaite, Marc Bennedbæk, Adrian G Zucco, et al.
Open Forum Infectious Diseases|September 29, 2025
Early versus deferred antiretroviral therapy initiation and long-term cardiovascular disease outcomes in people with HIV: The START studyNila J Dharan, Shweta Sharma, Alejandro Arenas-Pinto, et al.
The European Respiratory Journal|June 15, 2013
Short- and long-term mortality and causes of death in HIV/tuberculosis patients in EuropeDaria N Podlekareva, Alexander M Panteleev, Daniel Grint, et al.
AIDS (London, England)|December 7, 2023
Bone turnover change after randomized switch from tenofovir disoproxil to tenofovir alafenamide fumarate in men with HIVAmelia E B Moore, James E Burns, Deirdre Sally, et al.
AIDS (London, England)|February 10, 2018
No neurocognitive advantage for immediate antiretroviral treatment in adults with greater than 500 CD4+ T-cell countsEdwina J Wright, Birgit Grund, Kevin R Robertson, et al.
NEJM Evidence|May 22, 2023
Long-Term Benefits from Early Antiretroviral Therapy Initiation in HIV InfectionJens D Lundgren, Abdel G Babiker, Shweta Sharma, et al.
Pageof 8